Navigation Links
Influence of skin cancer on quality of life appears more substantial for women
Date:2/21/2011

Women seem to experience more health-related quality of life issues than men for up to 10 years following a diagnosis of the skin cancer melanoma, according to a report in the February issue of Archives of Dermatology, one of the JAMA/Archives journals.

"Although the prognosis is relatively good for about 80 percent of patients with melanoma, they remain at risk for disease progression and have an increased risk of developing subsequent melanomas," according to background information in the article from the authors. Previous studies have suggested about one-third of patients with melanoma have reported significant levels of distress. "Therefore, melanoma can be considered a chronic life-threatening disease that may affect patients' lives considerably."

To assess the impact of melanoma on the health-related quality of life of patients for up to 10 years after diagnosis, Cynthia Holterhues, M.D., from Erasmus MC, Rotterdam, the Netherlands, and colleagues, analyzed responses from a Dutch population-based postal survey among patients with melanoma for 1998 to 2008 using the Eindhoven Cancer Registry. Study participants were sent an impact of cancer survey to measure the well-being of long-term cancer survivors. The 41-item survey included questions on physical, psychological, social, existential, meaning of cancer and health worry.

The response rate to the survey was 80 percent (562 participants). The average age of the respondents was about 57 years, 62 percent were female and 76 percent had a melanoma with a thickness of less than 2 millimeters. "Women were significantly more likely to report higher levels of both positive and negative impacts of cancer," the authors write. The lowest scores were on questions about cancer or treatment-related symptoms of the cancer that interferes with a patients' socializing, traveling, or time with family. The highest score was seen on existential, positive outlook subscale, which covers increased wisdom and spirituality because of the cancer experience. "Women seemed to adjust their sun behavior more often (54 percent vs. 67 percent) than men and were more worried about the deleterious effects of UV radiation (45 percent vs. 66 percent)." In addition, the authors note that this cancer may also affect other parts of patients' lives. "A small proportion of individuals experienced difficulties in getting health insurance as a result of their melanoma, but up to a third of the patients experienced difficulty getting life insurance, disability insurance and/or a mortgage."

In conclusion, the authors write: "In clinical practice, this observation may imply that women need additional care, including follow-up and possibly counseling to optimally cope with their melanoma. However, men might be less aware of general measures of sun protection and need education about these measures after treatment."


'/>"/>

Contact: Tamar Nijsten, M.D., Ph.D.
t.nijsten@erasmusmc.nl
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Arranged unions and distrust: The influence of parental choice on mate guarding
2. Blood Protein Level May Not Influence Effectiveness of Statins
3. Ben-Gurion U. researchers determine that a first medical opinion can influence the second
4. Sex, race, and geography influence health outcomes following primary HIV infection
5. Sense of Touch May Influence Gender Perception
6. Friends a Big Influence on Grades in Middle School: Study
7. Family, friends, social ties influence weight status in young adults
8. Geography May Influence Colon Cancer Screening Rates
9. Type of Formula May Influence Infant Weight Gain
10. Grades in High School Might Influence Adult Health
11. Parents influence on childrens eating habits is limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: